BioSpace News Archive

ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that it has digitized the validation process at Dr. Reddy’s Laboratories across multiple sites, driven by ValGenesis VLMS – the industry’s most trusted electronic validation lifecycle management system.

NorthStar Medical Technologies, LLC, a global innovator in the development, production and commercialization of diagnostic and therapeutic radiopharmaceuticals, today announced the promotion of Chief Financial Officer Paul Estrem, to Executive Vice President.

NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, announced today an initiative to expand the Company’s digital health capabilities. Pivot Design Group (“Pivot”) – a leading Toronto boutique strategic design and communications agency specializing in service design, user experience design and communication design – will work with NeuPath

The American Red Cross announced a $7.5 million grant from Lilly Endowment Inc., in support of the organization’s disaster relief efforts underway throughout the United States.

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that CJ Barnum PhD, Head of Neurosciences will present data from the ongoing biomarker directed Phase Ib study of neuroinflammation in patients with Alzheimer’s disease. The talk entitled, Phase 1b Study in AD Patients with Neuroinflammati

Aetna®, a CVS Health® company, announced its 2021 Medicare offerings, featuring increased integration with CVS Health; expanded and differentiated Medicare Advantage plan options, including HMO and Dual Eligible Special Needs Plan offerings in new states; new Aetna Medicare Eagle™ plans designed especially for Veterans; and the lowest premium standalone prescription drug plan product in all 50 states and D.C.

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced that the company will present at two virtual investor conferences in October 2020.

Calgary, AB - Members of the Calgary, AB community who are in need of dental care and treatment solutions can get it from Beacon Smiles Dental.

Opthea Limited, a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, is pleased to announce that Jeremy Levin, DPhil, MB BChir will be appointed to the Company’s Board of Directors, effective October 12, 2020.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will release third quarter 2020 operating results after the close of the market on Monday, November 9, 2020.